Aspen Pharmacare
A global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets.
Launch date
Employees
Market cap
€5.3b
Enterprise valuation
€6.9b (Public information from Sep 2024)
Share price
ZAR191.8 APN.JO
Durban KwaZulu-Natal (HQ)
Financials
Estimates*
| ZAR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 38.6b | 37.8b | 38.6b | 40.7b | 44.8b | 50.2b | 53.6b |
| % growth | - | (2 %) | 2 % | 5 % | 10 % | 12 % | 7 % |
| EBITDA | 10.7b | 9.8b | 10.7b | 10.6b | 11.3b | 14.1b | 15.2b |
| % EBITDA margin | 28 % | 26 % | 28 % | 26 % | 25 % | 28 % | 28 % |
| Profit | 4.7b | 4.8b | 6.5b | 5.2b | 6.0b | 8.2b | 9.4b |
| % profit margin | 12 % | 13 % | 17 % | 13 % | 13 % | 16 % | 18 % |
| EV / revenue | 2.6x | 2.4x | 2.0x | 2.5x | 2.9x | 2.5x | 2.3x |
| EV / EBITDA | 9.4x | 9.2x | 7.3x | 9.5x | 11.4x | 9.0x | 8.1x |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
* | $30.0m | Grant | |
| Total Funding | €27.3m | ||
Recent News about Aspen Pharmacare
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.